Marathon Asset Management to acquire pharmaceutical firm Kaléo for $310m
Kaléo currently markets the AUVI-Q 0.15mg and 0.3mg, as well as the AUVI-q 0.1mg injections.
Diseases
EC grants approval for Merck-Eisai’s combo therapy for endometrial cancer
The approval is based on positive data from the Phase III KEYNOTE-775/Study 309 trial of...
Omicron variant minimally impacts Gritstone’s Covid-19 vaccines
Only 2% of the 146 non-Spike TCEs given within the vaccine currently in trials in...
Link Health to obtain global rights for Bone Therapeutics’ cell therapy
The new agreement is in addition to the deal entered last year to develop and...
Enzychem and Cadila collaborate to produce Covid-19 vaccine in Korea
The partnership between Enzychem and Cadila is expected to manufacture 80 million or more doses...
India seeks additional data from Serum Institute for Covovax approval
SII had sought authorisation in India for the Covid-19 vaccine for restricted use in emergencies.
Aztiq-Innobic consortium to buy Alvogen subsidiary for $475m
Aztiq founder Róbert Wessman will remain in position as Lotus and Adalvo's board chairman.
EMA recommends Pfizer-BioNTech’s Covid-19 vaccine for children
The EC will review the CHMP's guidance and decide whether to update the vaccine's conditional marketing authorisation.
Clover Biopharmaceuticals begins Covid-19 vaccine booster trial
The trial will analyse the safety and immunogenicity of the booster shot by enrolling healthy adults at several Brazilian sites.
Novavax seeks interim authorisation for Covid-19 vaccine in Singapore
The company’s filing includes positive clinical data from two Phase III trials.
GreenLight and Samsung Biologics to produce Covid-19 vaccines
Samsung will use GreenLight’s manufacturing process to produce the vaccines.
